This Government Contract opportunity from Department Of Defense was posted on September 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Sole Source – Oncotype DX Cancer Testing Services

Closed

HT941026N0123Federal

Submission Closed09/11/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

International

Clinical STI Screening and Treatment ServicesThe Clinical STI Screening and Treatment Services subcontract involves providing clinical screening, diagnosis, and medical management of sexually transmitted infections for prime contractors working on East Riding of Yorkshire Council sexual health projects. The scope of work specifically emphasizes Chlamydia screening for females aged 15 to 24 and the early detection of HIV to minimize late-stage presentations. These services are delivered using clinical diagnostic tools and medical examination facilities to ensure patients are accurately diagnosed and treated. The contract is aligned with the Public Health Outcomes Framework indicators, with a primary focus on delivering treated patients and reporting detection rates. Interested parties must respond by November 23, 2026, for this initiative managed by the East Riding of Yorkshire Council under NAICS code 621511.

East Riding of Yorkshire Council

POSTED

DEADLINE

RRC Drug and Alcohol Testing Laboratory ServicesThis subcontract for Residential Reentry Center projects under the Department of Justice involves providing specialized drug and alcohol testing laboratory services for prime contractors. The selected provider will be responsible for the collection and analysis of urine samples to detect narcotics and alcohol, ensuring the delivery of accurate test results and comprehensive reporting. The service provider must maintain strict adherence to regulatory standards, specifically 42 CFR Part 493 (CLIA), P.S. 6060, and P.S. 6590. Performance for this contract is centered in Springfield, falling under NAICS code 621511. Responses are due by November 12, 2026.

Residential Reentry - Co

POSTED

DEADLINE

In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

Solicitation # Project_1717

Supply Chain Coordination Limited, acting for NHS Supply Chain, is establishing an open national framework agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products, and Related Pathology Services. The scope of the procurement is extensive, covering pathology managed services, reagent rental agreements, pathology software, and core laboratory equipment and consumables across multiple disciplines, including biochemistry, microbiology, immunology, cellular pathology, virology, haematology, genomics, molecular testing, and reproductive sciences. Additionally, the framework includes point of care testing and specimen collection and storage. The procurement is organized into three distinct lots: Pathology Managed Services, Pathology Software Solutions, and Diagnostics Testing Solutions. The estimated total value for the initial period is 703,101,796 GBP excluding VAT, with a potential total value of approximately 2,545,824,000 GBP excluding VAT over the full eight-year framework duration. The estimated contract period runs from October 18, 2027, to October 17, 2029, with an overall framework end date of October 17, 2035. Proposals must be submitted electronically by December 16, 2026. Evaluation for Lots 1 and 2 is weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is evaluated based on 60 percent non-financial quality, 30 percent cost, and 10 percent social value.

Supply Chain Coordination Limited

POSTED

DEADLINE

Pathology ServicesThis subcontract for Pathology Services involves providing diagnostic pathology support for prime contractors working on projects for the Kingston University Higher Education Corporation. The scope of work includes the collection of biological samples and the execution of laboratory analysis utilizing specialized diagnostic equipment and pathology software to deliver comprehensive test results and diagnostic reports. To ensure quality and compliance, the provider must hold recognized laboratory accreditation, such as ISO 15189 or equivalent UK standards. Interested parties must submit their responses by the deadline of November 27, 2026, as specified in the solicitation posted on October 28, 2026.

Kingston University Higher Education Corporation

POSTED

DEADLINE

REBID - IN HOUSE DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140325

The Port Authority of New York and New Jersey is soliciting bids for solicitation number 6000003540 to establish a four year requirements contract for in house drug testing services. This procurement covers professional medical services and clinical laboratory reagents and tests, specifically categorized under NIGP codes 94874 and 19300. The contract is intended to provide comprehensive drug monitoring and diagnostic capabilities for the agency. Interested bidders must submit their proposals electronically via the Euna portal by the deadline of November 10, 2026. The Port Authority has ceased public bid openings, making electronic submission the only acceptable method. In accordance with Title VI of the Civil Rights Act of 1964, the agency ensures full and fair opportunity for all businesses regardless of race, color, national origin, age, or disability. For further assistance or technical issues, procurement operations can be reached at 150 Greenwich Street, 21st Floor, New York, New York 10007, via email at [email hidden], or by phone at [phone hidden].

The Port Authority of New York and New Jersey

POSTED

DEADLINE

REBID - FEDERAL DRUG TESTING SERVICES FOR THE PORT AUTHORITY OF NEW YORK AND NEW JERSEY – FOUR (4) YEAR REQUIREMENTS CONTRACT

Solicitation # 2140324

The Port Authority of New York and New Jersey is soliciting bids for solicitation number 6000003539, a rebid for a four year requirements contract to provide federal drug testing services. The scope of work encompasses professional medical services and clinical laboratory reagents and tests, specifically covering drug monitoring and diagnostic testing. Performance for this contract is designated as state wide within New York. Bids must be submitted electronically via the Euna portal by November 10, 2026, at 11:00 AM, as the Port Authority has temporarily ceased public bid openings. All inquiries and submissions are managed by the Procurement Operations Bid/RFP Custodian located at 150 Greenwich Street, New York, New York. In accordance with Title VI of the Civil Rights Act of 1964, the Port Authority ensures full and fair opportunity for all businesses regardless of race, color, national origin, age, or disability.

The Port Authority of New York and New Jersey

POSTED

DEADLINE

Clinical Blood Donor Panel Testing (Reference Laboratory Services)This subcontract involves providing clinical blood donor panel testing as a reference laboratory service for prime contractors supporting the Department of Veterans Affairs in North Chicago. The scope of work includes screening for various pathogens, including HIV, HBV, HCV, West Nile Virus, Chagas, Babesia, HTLV-I/II, and Anti-CMV, utilizing FDA-approved platforms. The service provider is responsible for managing specimen storage and conducting confirmation testing on all reactive results, with a strict requirement to deliver test result files within 24 hours. To ensure clinical quality and safety, the contractor must maintain CLIA certification and adhere to rigorous standards set by AABB, CAP, TJC, OSHA, the CDC, and the DoD. This opportunity falls under NAICS code 621511 and is managed through the Department of Veterans Affairs Network Contract Office 12.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Solicitation # 36C25227Q0071

The Department of Veterans Affairs is conducting market research via a sources sought synopsis to identify qualified providers for blood donor panel testing services at the Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. This requirement, categorized under NAICS code 621511 for Medical Laboratories, involves a five year ordering period consisting of five one year priced periods starting March 1, 2027. The selected contractor must provide all labor, materials, and expertise to perform a variety of tests, including standard donor panels, Anti-CMV, Chagas Antibody, West Nile Virus, and Babesia DNA/RNA, with estimated annual quantities ranging from 15 to 6,200 tests per category. The contractor must adhere to strict regulatory standards from the FDA, AABB, CAP, TJC, OSHA, CDC, and Department of Defense. Key performance requirements include a 95 percent success rate for reporting results within 24 hours of specimen receipt, with confirmation testing completed within seven calendar days. The contractor is responsible for providing specimen shipment containers and maintaining all necessary certifications, including CLIA and FDA approvals. The government reserves the right to conduct physical inspections of the contractor's facilities. Interested parties must submit organizational details and tailored capability statements by November 3, 2026, to help the government determine if the contract will be a small business set-aside, sole sourced, or open for full competition.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Initial Drug and Alcohol Screening ServicesThis subcontract opportunity with the City of Camden involves providing initial drug and alcohol screening services for prime contractors working on occupational health projects. The selected provider will be responsible for collecting specimens and performing laboratory analysis for alcohol and controlled substances using certified equipment and collection kits. To qualify, the service provider must operate a licensed medical facility or a CLIA certified laboratory and must be capable of delivering detailed screening reports and test results. The solicitation is categorized under NAICS code 621511 and was posted on October 26, 2026. Interested parties must submit their responses by the deadline of November 20, 2026, at 4:00 PM. This contract ensures that personnel on city projects meet necessary health and safety standards through professional medical screening and reporting.

POSTED

DEADLINE

Certified Drug Testing and Laboratory ServicesThis subcontract for Certified Drug Testing and Laboratory Services involves providing comprehensive drug screening and laboratory analysis for prime contractors working on Alabama Department of Workforce projects. The selected provider must offer local specimen collection sites and conduct all testing according to approved laboratory standards, ensuring the delivery of certified results and reports for employees. To ensure accuracy and compliance, the contractor is required to maintain CAP or NIDA accreditation and implement rigorous quality control and chain-of-custody procedures. This opportunity falls under NAICS code 621511 and is associated with the Alabama Human Resources agency.

POSTED

DEADLINE

Solicitation # SRC0000037369

The Alabama Department of Workforce is seeking a qualified vendor to establish an agreement for drug testing services. To be eligible, the selected laboratory must be approved by the College of American Pathologists or the National Institute on Drug Abuse and maintain strict written procedures for chain of custody and quality control. This includes the use of internal quality controls, blind samples for accuracy, a formal internal review and certification process for results, and robust security measures to prevent the adulteration of specimens. Additionally, the vendor must provide local sites for employee testing. The contract is managed by the State of Alabama Office of the Chief Procurement Officer and is subject to a total cost limit of 25,000 dollars or a maximum duration of five years, with the possibility of annual renewals. Award evaluation will be based on pricing, cost realism, and the verification of professional licenses and insurance. Vendors must be registered with the Alabama Secretary of State if they are foreign entities and must comply with the Beason-Hammon Alabama Taxpayer and Citizen Protection Act via E-Verify documentation. All submissions and inquiries must be processed electronically through the Alabama Buys Supplier Portal.

POSTED

DEADLINE

Forensic DNA Testing and STR/Y STR AnalysisThis subcontract for the City of Charlotte involves providing specialized forensic DNA testing and STR/Y STR analysis for prime contractors supporting Charlotte-Mecklenburg Police Department projects. The scope of work includes the screening of evidence, DNA extraction via manual or robotic methods, and the use of Globalfiler and Applied Biosystems 3500/3500xl Genetic Analyzers to amplify and type samples. Final analysis is conducted using GeneMapper ID-X software to deliver forensic reports and CODIS-eligible DNA profiles. To qualify, the provider must maintain ISO/IEC 17025 accreditation and ensure full compliance with 2025 FBI Quality Assurance Standards. The opportunity was posted on October 23, 2026, with a response deadline of November 23, 2026. This project falls under NAICS code 621511 and is managed through the City of Charlotte's procurement system.

City Of Charlotte

POSTED

5 days ago

DEADLINE

in 26 days

AI Contract Overview

The Defense Health Agency Healthcare Contracting Division-West intends to award a firm-fixed-price sole-source contract to Exact Sciences Laboratories, LLC (also referred to as Genomic Health, Inc.) for Oncotype DX branded genomic tumor-testing services. These services will support eligible patients at the Mike O’Callaghan Military Medical Center located at Nellis Air Force Base, Nevada. The contractor is responsible for providing all necessary specimen submission materials, performing the branded testing at their own facility, delivering written test results with professional interpretations, and returning any unstained slides or tissue tumor blocks to the government. The anticipated period of performance begins with a 12-month base period from September 16, 2026, through September 15, 2027, with the possibility of four subsequent 12-month option periods and one six-month extension. As this is a Notice of Intent to Sole Source under NAICS code 621511, it is not a request for competitive quotes. However, the government is accepting capability statements from interested sources until September 11, 2026, to determine if a competitive procurement is warranted or if the agency will proceed with the sole-source award.

General Info

Sole-source contract for Genomic Health to provide Oncotype DX testing at Nellis AFB.

Agency

Department Of Defense → Defense Health Agency Hcd West

NAICS

621511 - Medical Laboratories

Place of Performance

0, NV, 89191, USA

Set-Aside

NONE

Documents

HT941026N0123 Notice of Intent to Sole Source

special-notice

Low

HT941026N0123 - Notice of Intent to Sole Source for Oncotype DX Testing

sources-sought

Low

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedSep 7

special-notice

Notice updatedSep 9

The notice description changed.

Response DeadlineSep 11

Deadline has passed

Submission Closed

09/11/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Health Agency Hcd West

Contacts2 people available

OfficeCAMP PENDLETON, CA, 92055, USA

Organization / AgencyDepartment Of Defense → Defense Health Agency Hcd West

Office AddressCAMP PENDLETON, CA, 92055, USA

Contacts

Dominic Gonzales

contact@example.gov

Brandi Roberts

contact@example.gov

Full Description

The Defense Health Agency Contracting Activity, Healthcare Contracting Division–West, intends to negotiate and award a firm-fixed-price sole-source contract to EXACT SCIENCES LABORATORIES, LLC for Oncotype DX Cancer Testing Services in support of Mike O’Callaghan Military Medical Center, Nellis AFB, Nevada.

The requirement is for the specific Oncotype DX branded genomic tumor-testing service and associated report for eligible patients. The contractor shall provide materials necessary for specimen submission, perform required testing at the contractor’s facility, provide written test results and interpretation, and return tissue tumor blocks or unstained slides in accordance with the resulting contract.

The anticipated period of performance is 16 September 2026 through 15 September 2027, with four 12-month option periods and a potential six-month extension. This is a Notice of Intent to Sole Source and is not a request for competitive quotations or proposals. Interested sources may submit a capability statement by the response deadline stated in this notice.